Form 4: Clene Inc. Director Acquires Stock Options

Director Shalom Jacobovitz of Clene Inc. was granted stock options for 4,243 shares of common stock at an exercise price of $4.40 per share.

Summary

• Shalom Jacobovitz, a director at Clene Inc., was granted stock options on December 6, 2024.
• The options are for 4,243 shares of common stock.
• The exercise price for these options is $4.40 per share.
• The options vest immediately upon grant.
• The options expire on December 5, 2034.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants, which is neither particularly positive nor negative. It is a standard practice.

Positives

• The grant of stock options to a director may align their interests with those of shareholders.
• The immediate vesting of the options could incentivize the director to contribute to the company's success.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management interests with company performance.

Comparison to Industry Standards

• Stock option grants are a standard practice for compensating directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of immediately vesting is not uncommon, but can vary depending on the company's compensation policies.
• The exercise price of $4.40 per share is specific to Clene Inc. and would need to be compared to the current market price of the stock to assess its value.

Stakeholder Impact

• The stock option grant may have a minor positive impact on shareholder sentiment as it aligns director interests with company performance.

Key Dates

Keywords

stock options, director, Clene Inc., equity, insider trading, executive compensation